Global Psoriasis Drugs Market Research Report 2024

Report ID: 1898900 | Published Date: Jan 2025 | No. of Page: 82 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Psoriasis Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Tumor Necrosis Factor Inhibitor
        1.2.3 Interleukin Inhibitors
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Psoriasis Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Topicals
        1.3.3 Systemic
        1.3.4 Biologics
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Psoriasis Drugs Market Perspective (2017-2028)
    2.2 Psoriasis Drugs Growth Trends by Region
        2.2.1 Psoriasis Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Psoriasis Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Psoriasis Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Psoriasis Drugs Market Dynamics
        2.3.1 Psoriasis Drugs Industry Trends
        2.3.2 Psoriasis Drugs Market Drivers
        2.3.3 Psoriasis Drugs Market Challenges
        2.3.4 Psoriasis Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Psoriasis Drugs Players by Revenue
        3.1.1 Global Top Psoriasis Drugs Players by Revenue (2017-2022)
        3.1.2 Global Psoriasis Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Psoriasis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Psoriasis Drugs Revenue
    3.4 Global Psoriasis Drugs Market Concentration Ratio
        3.4.1 Global Psoriasis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Drugs Revenue in 2021
    3.5 Psoriasis Drugs Key Players Head office and Area Served
    3.6 Key Players Psoriasis Drugs Product Solution and Service
    3.7 Date of Enter into Psoriasis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Drugs Breakdown Data by Type
    4.1 Global Psoriasis Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028)
5 Psoriasis Drugs Breakdown Data by Application
    5.1 Global Psoriasis Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Psoriasis Drugs Market Size (2017-2028)
    6.2 North America Psoriasis Drugs Market Size by Country (2017-2022)
    6.3 North America Psoriasis Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Psoriasis Drugs Market Size (2017-2028)
    7.2 Europe Psoriasis Drugs Market Size by Country (2017-2022)
    7.3 Europe Psoriasis Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Psoriasis Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Psoriasis Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Psoriasis Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Psoriasis Drugs Market Size (2017-2028)
    9.2 Latin America Psoriasis Drugs Market Size by Country (2017-2022)
    9.3 Latin America Psoriasis Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Psoriasis Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Psoriasis Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Psoriasis Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 AbbVie
        11.1.1 AbbVie Company Detail
        11.1.2 AbbVie Business Overview
        11.1.3 AbbVie Psoriasis Drugs Introduction
        11.1.4 AbbVie Revenue in Psoriasis Drugs Business (2017-2022)
        11.1.5 AbbVie Recent Development
    11.2 Amgen
        11.2.1 Amgen Company Detail
        11.2.2 Amgen Business Overview
        11.2.3 Amgen Psoriasis Drugs Introduction
        11.2.4 Amgen Revenue in Psoriasis Drugs Business (2017-2022)
        11.2.5 Amgen Recent Development
    11.3 Johnson & Johnson
        11.3.1 Johnson & Johnson Company Detail
        11.3.2 Johnson & Johnson Business Overview
        11.3.3 Johnson & Johnson Psoriasis Drugs Introduction
        11.3.4 Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022)
        11.3.5 Johnson & Johnson Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Psoriasis Drugs Introduction
        11.4.4 Novartis Revenue in Psoriasis Drugs Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Eli Lilly & Company
        11.5.1 Eli Lilly & Company Company Detail
        11.5.2 Eli Lilly & Company Business Overview
        11.5.3 Eli Lilly & Company Psoriasis Drugs Introduction
        11.5.4 Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022)
        11.5.5 Eli Lilly & Company Recent Development
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Detail
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Psoriasis Drugs Introduction
        11.6.4 AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022)
        11.6.5 AstraZeneca Recent Development
    11.7 Celgene Corporation
        11.7.1 Celgene Corporation Company Detail
        11.7.2 Celgene Corporation Business Overview
        11.7.3 Celgene Corporation Psoriasis Drugs Introduction
        11.7.4 Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022)
        11.7.5 Celgene Corporation Recent Development
    11.8 UCB
        11.8.1 UCB Company Detail
        11.8.2 UCB Business Overview
        11.8.3 UCB Psoriasis Drugs Introduction
        11.8.4 UCB Revenue in Psoriasis Drugs Business (2017-2022)
        11.8.5 UCB Recent Development
    11.9 Merck
        11.9.1 Merck Company Detail
        11.9.2 Merck Business Overview
        11.9.3 Merck Psoriasis Drugs Introduction
        11.9.4 Merck Revenue in Psoriasis Drugs Business (2017-2022)
        11.9.5 Merck Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Psoriasis Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Tumor Necrosis Factor Inhibitor
    Table 3. Key Players of Interleukin Inhibitors
    Table 4. Key Players of Others
    Table 5. Global Psoriasis Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Psoriasis Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Psoriasis Drugs Market Share by Region (2017-2022)
    Table 9. Global Psoriasis Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Psoriasis Drugs Market Share by Region (2023-2028)
    Table 11. Psoriasis Drugs Market Trends
    Table 12. Psoriasis Drugs Market Drivers
    Table 13. Psoriasis Drugs Market Challenges
    Table 14. Psoriasis Drugs Market Restraints
    Table 15. Global Psoriasis Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Psoriasis Drugs Market Share by Players (2017-2022)
    Table 17. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021)
    Table 18. Ranking of Global Top Psoriasis Drugs Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Psoriasis Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Psoriasis Drugs Product Solution and Service
    Table 22. Date of Enter into Psoriasis Drugs Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Psoriasis Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Psoriasis Drugs Revenue Market Share by Type (2017-2022)
    Table 26. Global Psoriasis Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Psoriasis Drugs Revenue Market Share by Type (2023-2028)
    Table 28. Global Psoriasis Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Psoriasis Drugs Revenue Market Share by Application (2017-2022)
    Table 30. Global Psoriasis Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Psoriasis Drugs Revenue Market Share by Application (2023-2028)
    Table 32. North America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Psoriasis Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Psoriasis Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Psoriasis Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Psoriasis Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. AbbVie Company Detail
    Table 43. AbbVie Business Overview
    Table 44. AbbVie Psoriasis Drugs Product
    Table 45. AbbVie Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 46. AbbVie Recent Development
    Table 47. Amgen Company Detail
    Table 48. Amgen Business Overview
    Table 49. Amgen Psoriasis Drugs Product
    Table 50. Amgen Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 51. Amgen Recent Development
    Table 52. Johnson & Johnson Company Detail
    Table 53. Johnson & Johnson Business Overview
    Table 54. Johnson & Johnson Psoriasis Drugs Product
    Table 55. Johnson & Johnson Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 56. Johnson & Johnson Recent Development
    Table 57. Novartis Company Detail
    Table 58. Novartis Business Overview
    Table 59. Novartis Psoriasis Drugs Product
    Table 60. Novartis Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 61. Novartis Recent Development
    Table 62. Eli Lilly & Company Company Detail
    Table 63. Eli Lilly & Company Business Overview
    Table 64. Eli Lilly & Company Psoriasis Drugs Product
    Table 65. Eli Lilly & Company Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 66. Eli Lilly & Company Recent Development
    Table 67. AstraZeneca Company Detail
    Table 68. AstraZeneca Business Overview
    Table 69. AstraZeneca Psoriasis Drugs Product
    Table 70. AstraZeneca Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 71. AstraZeneca Recent Development
    Table 72. Celgene Corporation Company Detail
    Table 73. Celgene Corporation Business Overview
    Table 74. Celgene Corporation Psoriasis Drugs Product
    Table 75. Celgene Corporation Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 76. Celgene Corporation Recent Development
    Table 77. UCB Company Detail
    Table 78. UCB Business Overview
    Table 79. UCB Psoriasis Drugs Product
    Table 80. UCB Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 81. UCB Recent Development
    Table 82. Merck Company Detail
    Table 83. Merck Business Overview
    Table 84. Merck Psoriasis Drugs Product
    Table 85. Merck Revenue in Psoriasis Drugs Business (2017-2022) & (US$ Million)
    Table 86. Merck Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Psoriasis Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Tumor Necrosis Factor Inhibitor Features
    Figure 3. Interleukin Inhibitors Features
    Figure 4. Others Features
    Figure 5. Global Psoriasis Drugs Market Share by Application in 2021 & 2028
    Figure 6. Topicals Case Studies
    Figure 7. Systemic Case Studies
    Figure 8. Biologics Case Studies
    Figure 9. Psoriasis Drugs Report Years Considered
    Figure 10. Global Psoriasis Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Psoriasis Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Psoriasis Drugs Market Share by Region: 2021 VS 2028
    Figure 13. Global Psoriasis Drugs Market Share by Players in 2021
    Figure 14. Global Top Psoriasis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Drugs as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Psoriasis Drugs Revenue in 2021
    Figure 16. North America Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Psoriasis Drugs Market Share by Country (2017-2028)
    Figure 18. United States Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Psoriasis Drugs Market Share by Country (2017-2028)
    Figure 22. Germany Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Psoriasis Drugs Market Share by Region (2017-2028)
    Figure 30. China Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Psoriasis Drugs Market Share by Country (2017-2028)
    Figure 38. Mexico Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Psoriasis Drugs Market Share by Country (2017-2028)
    Figure 42. Turkey Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Psoriasis Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. AbbVie Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 45. Amgen Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 46. Johnson & Johnson Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 47. Novartis Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 48. Eli Lilly & Company Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 49. AstraZeneca Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 50. Celgene Corporation Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 51. UCB Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 52. Merck Revenue Growth Rate in Psoriasis Drugs Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
AbbVie
Amgen
Johnson & Johnson
Novartis
Eli Lilly & Company
AstraZeneca
Celgene Corporation
UCB
Merck
Frequently Asked Questions
Psoriasis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Psoriasis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Psoriasis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Quinoa

This report aims to provide a comprehensive presentation of the global market for Quinoa, with bo ... Read More